01.07.2014 Views

Beacon Pharmaceuticals Ltd------- Prospectus

Beacon Pharmaceuticals Ltd------- Prospectus

Beacon Pharmaceuticals Ltd------- Prospectus

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Light for Life<br />

BEACON<br />

07.00 Number of employee and salary:<br />

The company paid an aggregate amount more than 3,000 to1042 employee. The different ranges salaried employees<br />

are stated bellow:<br />

Salary Range<br />

No. of Employee<br />

3,000 to 10,000 1040<br />

10,000 to 15,000 165<br />

15,000 to 25,000 40<br />

25,000 to 50,000 09<br />

50,000 above 10<br />

Total 1264<br />

08.00 Share Capital of the Company:<br />

As on 30.06.2009, the paid-up share capital of the Company was Tk 60,00,00,000 divided into 6,00,00,000 ordinary<br />

shares of Tk.10.00 each. Subsequently the Company issued 100,000,000 ordinary shares of Tk. 10.00 each<br />

amounting to Tk. 1,000,000,000.00 on 24.09.2009, which consent has been accorded by the Securities and Exchange<br />

Commission on 04.08.2009 and issued 30,000,000 ordinary shares of Tk. 10.00 each amounting to Tk.<br />

300,000,000.00 on 30.12.2009, which consent has been accorded by the Securities and Exchange Commission on<br />

25.10.2009. Considering the above events, the paid-up capital of the Company stands at Tk. 1,900,000,000.00.<br />

Dated: Dhaka<br />

30 December 2009<br />

Sd/-<br />

(M. A. Malek Siddiqui Wali & Co.)<br />

Chartered Accountants<br />

9.00 There is no amount due from Directors, Managers and Officers of the company.<br />

No amount is due from any associate undertaking and related parties as on 30-06-2009.<br />

No provision has been made for any debt.<br />

Total amount of receivable due from local customers.<br />

10.00<br />

11.00 Restated EPS =<br />

18,473,433<br />

190,000,000 = 0.10<br />

Restated EPS Calculated considering the increased paid up capital of Tk.130 crore after the balance sheet.<br />

12.00<br />

Managing Director & Director has spent fund of Tk. 59.75 crore from their own source to construct factorybuilding,<br />

development of factory land and to purchase machineries. Subsequently these assets has transferred<br />

to <strong>Beacon</strong> <strong>Pharmaceuticals</strong> <strong>Ltd</strong>. by Vendors agreement and against this asset they have received 59,75,000<br />

fully paid ordinary shares @ Tk. 100.00 each in two phase (1st phase 4,75,000 fully paid ordinary shares @ Tk.<br />

100.00 each vendors agreement date 20th October 2003 and 2nd phase 55,00,000 fully paid ordinary shares<br />

@ Tk. 100.00 each vendors agreement date 20th April 2005).<br />

The company pays salaries & allowances on accrual basis i.e, current's month salary is accrued for the month<br />

and it is pay in immediate next month. The accrued salary & allowances of Tk. 68,72,592 was payable for the<br />

month of June'09 and subsequently it was paid in next month so at the date of signing of audit report above<br />

accrued salary & allowances has paid.<br />

Dated: Dhaka<br />

23 March 2010<br />

Sd/-<br />

(M. A. Malek Siddiqui Wali & Co.)<br />

Chartered Accountants<br />

75<br />

PROSPECTUS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!